This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1039/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57087096
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у 2010 article scientifique publié en 2010 artículu científicu im Januar 2010 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q57087096-14A9E3AF-8EFC-4284-AD91-85810CEDC9C2
wdt:P577
2010-01-01T00:00:00Z
p:P407
wds:Q57087096-A9B22B15-EB59-4644-95AC-A38DD258930A
wdt:P407
wd:Q1860
p:P2093
wds:Q57087096-EEBBE072-FCD9-4049-B3F0-4CB10518E562
wdt:P2093
Katharina Bica
rdfs:label
Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts
skos:prefLabel
Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts
schema:name
Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts
p:P50
wds:Q57087096-664B7CEC-5F25-436B-B524-8E6695A2CAA3
wdt:P50
wd:Q43004083
p:P1476
wds:Q57087096-A74F7B55-8F21-4612-B9EC-5AB86D23C5FE
wdt:P1476
Confused ionic liquid ions—a “liquification” and dosage strategy for pharmaceutically active salts
p:P304
wds:Q57087096-97A90A0E-1F44-45AF-95F4-DED8E7FF3CE4
wdt:P304
1215
p:P31
wds:Q57087096-3EC87619-2405-49F2-B0A6-BF59C30183B7
wdt:P31
wd:Q13442814
p:P921
wds:Q57087096-C4093675-D3D6-47E3-8CDD-7F1BF4B0F230
wdt:P921
wd:Q11435
p:P698
wds:Q57087096-15BF1AB6-693D-4EFD-8DAE-0C715158C8DD
wdtn:P698
n12:20449254
wdt:P698
20449254
p:P1433
wds:Q57087096-E6F491B0-7BF2-4156-A1AF-E17C9344F06D
wdt:P1433
wd:Q426303
p:P433
wds:Q57087096-EFFD247B-07E7-49D1-86F5-343E9DB63501
p:P478
wds:Q57087096-543D4D1B-F9C6-4B76-975B-21392D2F69F9
wdt:P433
8
wdt:P478
46
p:P356
wds:Q57087096-3A97B8C7-85B0-4672-A7D3-3D42AA7CE351
wdtn:P356
n9:B925147B
wdt:P356
10.1039/B925147B